ALLMedicine™ Venous Thromboembolism Center

Mar 18th, 2023 - This review aims to assess the treatment options for cancer-associated venous thromboembolism (VTE) based on the most robust level of evidence recommendations and suggestions based on expert opinion. Several classes of anticoagulants have been stu...

Mar 18th, 2023 - Implementation of international guidelines in Latin American settings requires additional considerations (i.e., values and preferences, resources, accessibility, feasibility, and impact on health equity). To provide evidence-based guidelines about...

Mar 18th, 2023 - Thyroid dysfunction plays an important role in the development of cardiovascular disease. However, its relationship with venous thromboembolism (VTE) remains unclear. We performed a meta-analysis of published cohort and case-control studies to inv...

Mar 17th, 2023 - Venous thromboembolism (VTE) causes significant morbidity in pediatric trauma patients. We applied machine learning algorithms to the Trauma Quality Improvement Program (TQIP) database to develop and validate a risk prediction model for VTE in inj...

Mar 16th, 2023 - Surgical quality improvement collaboratives (QICs) aim to improve patient outcomes through coaching, benchmarked data reporting, and other activities. While other regional QICs have formed organically over time, it is unknown whether a comprehensi...

Mar 16th, 2023 - Despite the growing number of pediatric antithrombotic clinical trials, standardized safety and efficacy outcome definitions for pediatric venous thromboembolism (VTE) clinical trials have not been updated since 2011. Many recent trials have adapt...

Mar 13th, 2023 - As of February 2023, more than 754 million confirmed cases of COVID-19 have occurred worldwide.1 Venous thromboembolism (VTE) has been recognized as an important complication of COVID-19.2 Most studies have focused on VTE outcomes occurring among ...

Feb 17th, 2023 - Oral anticoagulation therapy has evolved beyond vitamin K antagonists to include oral direct thrombin inhibitors and factor Xa inhibitors. Collectively known as "direct oral anticoagulants," this class of medications represents the current standar...

Jan 14th, 2023 - Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline.|2023|Falanga A,Ay C,Di Nisio M,Gerotziafas G,Jara-Palomares L,|

Jul 1st, 2022 - Importance: Dose-reduced regimens of direct oral anticoagulants (DOACs) may be used for 2 main purposes: dose-adjusted treatment intended as full-intensity anticoagulation (eg, for stroke prevention in atrial fibrillation [AF] in patients requirin...

Mar 15th, 2023 - Stroke is one of the top medical conditions resulting in high mortality among patients in hospitals, where complications related to immobility such as deep vein thrombosis (DVT) and/or ankle joint contracture can affect patients in their road to r...

Mar 13th, 2023 - As of February 2023, more than 754 million confirmed cases of COVID-19 have occurred worldwide.1 Venous thromboembolism (VTE) has been recognized as an important complication of COVID-19.2 Most studies have focused on VTE outcomes occurring among ...

Mar 10th, 2023 - Currently, Enoxaparin is the usual prophylactic anticoagulant treatment at the acute and sub-acute phases of spinal cord injury (SCI). Patients at the sub-acute phase of SCI (rehabilitation) will be given either Enoxaparin 40 mg/day (control) or A...

Mar 8th, 2023 - Venous thromboembolism (VTE) is common especially among post-operative patients, and its occurrence is associated with significant morbidity and mortality. VTE is highly preventable with prophylactic modalities ranging from conservative measures s...

Mar 6th, 2023 - The objective is to demonstrate the non-inferiority of edoxaban to standard of care (SOC; including low molecular weight heparin (LMWH), vitamin K antagonist (VKA), or synthetic pentasaccharide (SP) Xa inhibitors) in the treatment and secondary pr...

Mar 16th, 2023 - Overall risk for venous thromboembolism (VTE) was low for typical COVID outpatients, though higher rates were identified in certain groups, suggesting opportunity for targeted interventions or increased short-term surveillance, according to author...

Mar 14th, 2023 - Overall risk for venous thromboembolism (VTE) in nonhospitalized COVID-19 patients is low, but some of those patients may have factors that increase the risk and warrant more surveillance, according to a new retrospective cohort study. Though VTE.

Mar 13th, 2023 - As of February 2023, more than 754 million confirmed cases of COVID-19 have occurred worldwide.1 Venous thromboembolism (VTE) has been recognized as an important complication of COVID-19.2 Most studies have focused on VTE outcomes occurring among ...

Feb 21st, 2023 - A diagnostic workup for pulmonary embolism (PE) should be performed in all patients with recent onset of exertional dyspnea, according to the authors of an article published in the Journal of Thrombosis and Haemostasis. That conclusion emerged fro.

Jan 18th, 2023 - For patients with a variety of traumatic bone fractures, plain old oral aspirin provided just as good thromboprophylaxis as traditional low-molecular-weight heparin (LMWH) injections in the large PREVENT CLOT randomized trial. Aspirin met noninfer...